Latest News Archive
Please select Category, Year, and then Month to display items
![]()
The National Research Foundation (NRF) ratings are considered the benchmark for research excellence. This year the University of the Free State (UFS) has 17 newly NRF-rated researchers. This brings the total number of NRF-rated researchers at UFS to 160.
NRF ratings are allocated based on a researcher’s recent research outputs and impact as perceived by national and international peer reviewers. The rating system encourages researchers to publish high-quality research papers in journals of high impact and to publish books through reputed academic publishers. The NRF rating system is a valuable tool for benchmarking the quality of our researchers against the best in the world.
Research at the heart of the UFS
Prof Francis Petersen, Rector and Vice-Chancellor, has indicated that the UFS provides significant support to researchers to apply for new NRF ratings or to re-apply for rating. These initiatives include the mock NRF rating panels managed by the Prestige Scholars Programme (PSP), evaluation of individual research outputs and recommendations on timely applying for rating, and improvements on rating applications by a panel consisting of internal and external members. These initiatives are bearing fruit by increasing the number of rated researchers who will transform the research profile and increase the diversity of UFS researchers.
Cultivating the best researchers.
According to Eleanor van der Westhuizen, from Research Development: “The rating of individuals is based primarily on the quality and impact of their research outputs over the past eight years, taking into consideration the evaluation made by local and international peers. It identifies researchers who count among the leaders in their fields of expertise and gives recognition to those who have a sustained production of high-quality research outputs. Several South African universities use the outcomes of the NRF evaluation and rating process to position themselves as research-intensive institutions, while others such as the UFS provide incentives for their staff members to acquire and maintain a rating.”
Cream of the crop
The UFS has also upped the ante with regard to its total number of NRF-rated researchers during the latest rating and evaluation, with an increase from 149 to 160 rated researchers in 2018.
Prof Heidi Hudson, Dean of Humanities, received an NRF B-rating, which brings the total of B-rated researchers to six. Other B-rated researchers incude Prof Johann Meyer (Mathematics), Prof Fanie Snyman and Prof Francois Tolmie (Theology), Prof Felicity Burt (Medical Microbiology) and Prof Andre Roodt (Chemistry). A total number of 10 new C-ratings and six new Y-ratings were achieved during the 2018 evaluation process.
“NRF-rating is indicative of the university’s drive to enhance its research profile nationally and internationally. Congratulations to all the scientists and scholars who received a rating in 2017. I am thankful to our academics for their commitment to the rating process,” said Prof Corli Witthuhn, Vice-Rector: Research at the UFS.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004